Research institute in
Pfäffikon SZ

Oerlikon Surface Solutions AG, Pfäffikon

Since 1995 · 21–50 empl.

Oerlikon Surface Solutions AG, Pfäffikon provides surface solutions for industrial applications. Its portfolio includes materials, coating equipment, coating services and technical support, with a focus on thermal spray technologies.

IFCC Foundation for Emerging Nations

Since 2016 · 11–20 empl.

IFCC Foundation for Emerging Nations is a charitable foundation that funds and supports projects to improve the quality and delivery of laboratory medicine services, particularly in emerging nations. Its support includes educational projects and training in laboratory medicine.

LamKap Bio beta AG

Since 2017 · 1–10 empl.

LamKap Bio beta AG is a biotechnology company researching and developing bispecific antibodies for cancer treatment. Its development program includes NILK-2401, an antibody targeting CEA and CD47 for solid tumors.

LamKap Bio alpha AG

Since 2018 · 1–10 empl.

LamKap Bio alpha AG develops bispecific antibodies for cancer immunotherapy. Its development programs include antibodies targeting CEA on tumor cells to redirect T cells toward them or enhance T-cell activity.

LamKap Bio gamma AG

Since 2018 · 1–10 empl.

LamKap Bio gamma AG develops bispecific antibodies for the treatment of solid tumors. Its pipeline includes candidates targeting GPC3 and CD3 or CD28, currently in discovery and early preclinical development.

Mindfire AG

Since 2019 · 11–20 empl.

Mindfire AG advances artificial intelligence by engaging talent in research through gamified challenges, online games and competitions. Its activities include Lab42 and projects exploring human intelligence and AI.

discoveric bio beta ag

Since 2019 · 21–50 empl.

discoveric bio beta ag develops antibody therapies for antimicrobial-resistant infections. Its pipeline includes fully human κλ IgG antibodies targeting infections caused by Gram-negative bacteria, including bloodstream and lung infections.

discoveric marina ag

Since 2020 · 21–50 empl.

discoveric marina ag develops fully human bi- and multi-specific antibodies and advances programs targeting Alzheimer’s disease, neuroinflammation and antimicrobial‑resistant infections.

discoveric marketplace ag

Since 2021 · 21–50 empl.

discoveric marketplace ag develops fully human bi- and multi-specific IgG antibodies and advances therapeutic programs focused on Alzheimer’s disease, neuroinflammation and antimicrobial‑resistant infections.

Medable GmbH

Since 2021 · 1–10 empl.

Medable GmbH provides digital solutions for conducting clinical trials. Its platform includes electronic clinical outcome assessment (eCOA), electronic consent (eConsent), and tools for planning, monitoring, and managing studies.

K2tech AG

Since 2023 · 1–10 empl.

K2tech AG develops and supplies sensor, data acquisition and edge computing systems, as well as software for industrial applications. Its services include real-time data analysis, AI, automation and engineering for machinery and production processes.

LRE Medical Switzerland AG

Since 2024 · 1–10 empl.

LRE Medical Switzerland AG is a contract development and manufacturing organization (CDMO) specializing in the development and industrialization of complex diagnostic, medical and life‑science devices. Services include product development and engineering, production engineering and manufacturing, quality and regulatory support, and lifecycle management with after‑sales services for point‑of‑care and benchtop laboratory instruments.